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2570Undetectable High-Sensitivity Cardiac Troponin T Level in the
Emergency Department and Risk of Myocardial InfarctionObjectives This study sought to evaluate if an undetectable (<5 ng/l) high-sensitivity cardiac troponin T (hs-cTnT) level and
an electrocardiogram (ECG) without signs of ischemia can rule out myocardial infarction (MI) in the emergency
department (ED).Background Chest pain is a common symptom often associated with benign conditions, but may be a sign of MI. Because there
is no rapid way to rule out MI, many patients are admitted to the hospital.Methods All patients who sought medical attention for chest pain and had at least 1 hs-cTnT analyzed during 2 years at
the Karolinska University Hospital, Stockholm, Sweden, were included. We calculated the negative predictive values
of an undetectable hs-cTnT and ECG without ischemia for MI and death within 30 days.Results We included 14,636 patients, of whom 8,907 (61%) had an initial hs-cTnT of <5 ng/l; 21% had 5 to 14 ng/l,
and 18% had >14 ng/l. During 30-day follow-up, 39 (0.44%) patients with undetectable hs-cTnT had a MI, of whom
15 (0.17%) had no ischemic ECG changes. The negative predictive value for MI within 30 days in patients with
undetectable hs-cTnT and no ischemic ECG changes was 99.8% (95% conﬁdence interval [CI]: 99.7 to 99.9). The
negative predictive value for death was 100% (95% CI: 99.9 to 100).Conclusions All patients with chest pain who have an initial hs-cTnT level of <5 ng/l and no signs of ischemia on an ECG have
a minimal risk of MI or death within 30 days, and can be safely discharged directly from the ED. (J Am Coll Cardiol
2014;63:2569–78) ª 2014 by the American College of Cardiology FoundationChest pain is the cardinal symptom of myocardial infarction
(MI), and it is one of the most common complaints of
patients seeking medical attention in the emergency
department (ED), accounting for an estimated 15 to 20
million ED visits per year in Europe and the United States
(1–3). Although chest pain is often merely a sign of a
completely benign condition, it may indicate that the patient
is experiencing a life-threatening disease. As much as 2% of
patients with MI are inadvertently discharged directly from
the ED, which is associated with a doubling of the risk of
death (4). Current guidelines therefore recommend that
patients with chest pain who have normal clinical ﬁndings,
electrocardiograms (ECGs), and cardiac injury markers in
the ED should have biomarker testing repeated 3 to 6 h after
presentation (2). Commonly, this means that the patient
is admitted to the hospital for further evaluation. However,
only 10% to 20% of patients admitted for chest pain are
diagnosed with MI during hospital stay (4–6).
If MI can be ruled out safely and efﬁciently, without serial
testing or prolonged observation, then hospital admissions,
ED overcrowding, and costs could be reduced. Several
clinical decision rules have been developed to safely and
efﬁciently exclude MI, which include assessment of pretest
probability, biomarker levels, and ECG ﬁndings (6–9).
However, these algorithms all include serial testing of bio-
markers, which may delay patient discharge from the ED.
Recently, high-sensitivity cardiac troponin T (hs-cTnT)
has been introduced as a highly sensitive and early biomarker
of myocardial damage (10). In 2 prospective cohorts of
patients admitted to the hospital for chest pain, undetectablehs-cTnT was found to have a very high negative predictive
value for MI (5,11).
We hypothesized that all patients with chest pain who
have an initial hs-cTnT level of <5 ng/l and no signs of
ischemia on an ECG have a minimal risk of MI or death
within 30 days, and can be safely discharged directly from
the ED.Methods
Study population. This study included all patients
age >25 years who sought medical attention for chest pain
in the ED and had at least 1 hs-cTnT level measured at
Karolinska University Hospital, Stockholm, Sweden, from
December 10, 2010 to December 31, 2012. This hospital is
located at 2 sites that are 22 km apart (Huddinge and Solna),
and has a total capacity of 1,610 beds. The annual number of
patients presenting to the adult ED is approximately 77,000
in Huddinge and 70,000 in Solna. Coronary angiography
and percutaneous coronary intervention (PCI) are available
at Huddinge during ofﬁce hours, and at all times at Solna.
Patients who presented to the ED were identiﬁed from
the hospitals’ register of patients. Archived laboratory data
were retrieved to determine which patients had at least
1 hs-cTnT level measured while in the ED. Serum creati-
nine levels measured in the ED were retrieved to assess
renal function, and the time spent in the ED was recorded.
Patient data were then sent to the National Board of
Health and Welfare to obtain data from the Swedish
National Patient Register (12), which includes all patients
Abbreviations
and Acronyms
CI = conﬁdence interval
ECG = electrocardiogram
ED = emergency department
eGFR = estimated
glomerular ﬁltration rate
hs-cTnT = high-sensitivity
cardiac troponin T
MI = myocardial infarction
NSTEMI = non–ST-segment
elevation myocardial
infarction
PCI = percutaneous coronary
intervention
STEMI = ST-segment
elevation myocardial
infarction
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2571hospitalized in Sweden, regarding previous hospital stay for
MI, stroke, heart failure, or chronic obstructive pulmonary
disease, to determine the background characteristics of the
study population. Information about current medications
was retrieved from the Swedish Prescribed Drug Register
(13). The data were then de-identiﬁed and returned to the
investigators.
Diabetes mellitus was deﬁned as ongoing treatment with
any hypoglycemic agent. The estimated glomerular ﬁltration
rate (eGFR) was calculated using the Chronic Kidney Dis-
ease Epidemiology Collaboration formula. Chronic kidney
disease was deﬁned as an eGFR of <60 ml/min/1.73 m2.
The study protocol complied with the guidelines of the
Declaration of Helsinki and was approved by the Regional
Ethical Review Board in Stockholm.
The main group of patients studied were those with a ﬁrst
hs-cTnT level of <5 ng/l (undetectable) measured in the
ED, combined with no ST-segment changes, indicating
myocardial ischemia on the ECG (2). Patients with a ﬁrst
hs-cTnT level of<5 ng/l and initial ECG changes indicating
MI were excluded from further analysis. In patients with a
ﬁrst hs-cTnT level of 5 ng/l, the ECGs were not reviewed.
The hs-cTnT levels were analyzed using the Elecsys 2010
system (Roche Diagnostics GmbH, Mannheim, Germany),
which has been available at Karolinska University Hospital
since December 10, 2010. This method has a detection limit
of 5 ng/l, a limit of blank of 3 ng/l, a 99th percentile cutoffFigure 1 Study Population
The selection of the study population, and number of patients at different levels of high-s
ED ¼ emergency department.point of 14 ng/l, and a coefﬁcient
of variation of <10% at 13 ng/l
(14). Patients were categorized
into 3 groups according to the
ﬁrst hs-cTnT level: <5, 5 to 14,
and >14 ng/l.
Outcome and follow-up. The
primary outcome was fatal or
nonfatal type 1 MI, which is
deﬁned as MI related to athero-
sclerotic plaque rupture, ﬁs-
suring, or erosion that leads to an
intraluminal thrombus forma-
tion, resulting in myocardial
ischemia (2) within 30 days of
the ED visit. The secondary
outcomes were MI within 180
and 365 days of the ED visit,
and all-cause mortality within
30, 180, and 365 days of the ED visit. In patients with a ﬁrst
hs-cTnT level of <5 ng/l, the hazard ratio for all-cause
mortality was calculated for admitted patients compared
with patients discharged directly from the ED.
Patients were followed from the time of the ﬁrst hs-cTnT
level until 30, 180, or 365 days after the ED visit. Data
regarding subsequent diagnosis of MI, hospital stays,
discharge diagnoses other than MI, and length of hospitalensitivity cardiac troponin T (hs-cTnT), which are reported in nanograms per liter.
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2572stay were obtained from the Swedish National Patient
Register. Causes of death were obtained from the Cause-
of-Death Register, which includes all individuals who
reside in Sweden at the time of their death.
Review of electrocardiograms and diagnoses of
myocardial infarction. All patients with a ﬁrst hs-cTnT
level of <5 ng/l and a diagnosis of MI within 30 days
were identiﬁed, and their ECGs were retrieved from the
medical records. ECGs were also retrieved for 2 control
patients per case from the cohort of patients who visited the
ED because of chest pain, matched for age, sex, and the ﬁrst
hs-cTnT level, and who were not diagnosed with MI within
30 days. Two independent senior cardiologists, blinded to
the study protocol, were asked to review the ECGs and
assess whether there was new ST-segment elevation in 2
contiguous leads with cutpoints of 0.1 mV in all leads,
except for leads V2 to V3, where 0.2 mV in men 40 years
of age and 0.25 mV in men <40 years of age and 0.15
mV in women were applied. These cardiologists also
reviewed if there was any signiﬁcant ST-segment depression,
deﬁned as a horizontal or downsloping ST-segment 0.05
mV in 2 contiguous leads, or if there was a left bundle
branch block present that was new compared with previous
ECGs (if there were previous ECGs to compare with) (2).
The only data available to the senior cardiologists were the
age and sex of each patient, and that the main complaint was
chest pain. A third senior cardiologist (M.J.H.) also assessed
all the ECGs, and if there was disagreement between the
assessments by the 2 independent cardiologists, the assessment
by M.J.H. was used for the analyses. At a later stage, the re-
cords of all patients with a ﬁrst hs-cTnT level of <5 ng/l, andTable 1
Characteristics of the Study Population Ac
First High-Sensitivity Cardiac Troponin T L
Characteristics All Patients (N ¼ 14,63
Percentage of study population 100
Age, yrs 55  19
Female, % 48
eGFR
>60 ml/min/1.73 m2, % 88
30–60 ml/min/1.73 m2, % 10
15–30 mL/min/1.73 m2, % 2.1
eGFR, ml/min/1.73 m2 90  25
Diabetes mellitus, % 9.5
COPD, % 3.4
Previous MI, % 8.5
Previous stroke, % 4.9
Previous hospital stay for CHF, % 5.7
Aspirin, % 19
Beta-blockers, % 23
ACE/ARB, % 24
Statins, % 19
Values are % or mean  SD.
ACE/ARB ¼ angiotensin-converting enzyme inhibitor/angiotensin-receptor
pulmonary disease; eGFR ¼ estimated glomerular ﬁltration rate; MI ¼ myocarno MI within 30 days, were reviewed to determine whether
they met the criteria for MI within 30 days according to
troponin levels, other laboratory values, coronary angiographic
ﬁndings, echocardiographic ﬁndings, and ECG ﬁndings.
Statistical analyses. We stratiﬁed patients into 3 groups
according to level of hs-cTnT (<5, 5 to 14, and >14 ng/l)
and calculated the absolute risks, negative predictive values,
and incidence rates with 95% conﬁdence intervals (CIs)
for MI and death with a follow-up of 30, 180, and 365 days.
The ﬁrst hs-cTnT level recorded from December 10, 2010
to December 31, 2012 was the starting point of the follow-
up for each patient. The Cox proportional hazards model
was used to calculate hazard ratios and 95% CIs for the
potential association between the exposure not admitted
(reference admitted) and the outcome time to death adjusted
for age, sex, diabetes mellitus, previous MI, and eGFR. The
data management and the calculations for absolute risks,
negative predictive values, and incidence rates were con-
ducted using the World Programming System, version 3.0
(World Programming Ltd., Hampshire, United Kingdom).
The Cox proportional hazards model was performed using
R version 3.0.2 (R Foundation for Statistical Computing,
Vienna, Austria).Results
Patient characteristics. There were a total of 330,821 visits
to the adult ED at Karolinska University Hospital during
the study period (Fig. 1). Chest pain was the second most
common reason for visiting the ED, accounting for 15,549
(4.7%) patients, of whom 14,636 were aged >25 years andcording to the
evel
6)
High-Sensitivity Cardiac Troponin T Level (ng/l)
<5 (n ¼ 8,907) 5–14 (n ¼ 3,150) >14 (n ¼ 2,579)
61 21 18
47  15 63  16 71  15
53 41 37
98 85 57
2.4 15 32
0.03 0.74 11
99  18 82  21 65  28
4.7 14 21
1.6 5.0 7.6
4 12 21
2.1 7 13
1.4 7.3 19
9.7 30 40
13 36 47
13 35 46
11 28 34
blocker. CHF ¼ congestive heart failure; COPD ¼ chronic obstructive
dial infarction.
Table 2
Absolute Risks and Negative Predictive Values for Myocardial Infarction or Death
at 30, 180, and 365 Days After Discharge From the ED*
Characteristics
High-Sensitivity Cardiac Troponin T Level (ng/l)
<5 (n ¼ 8,883)y 5–14 (n ¼ 3,150) >14 (n ¼ 2,579)
Proportion admitted 1,917 (21) 1,397 (44) 2,104 (82)
Myocardial infarction
30 days
No. of events 15 97 676
Absolute risk 0.17 (0.09–0.27) 3.08 (2.48–3.68) 26.2 (24.5–27.9)
Negative predictive value 99.8 (99.7–99.9) 96.9 (96.3–97.5) 73.8 (72.1–75.5)
180 days
No. of events 33 115 724
Absolute risk 0.37 (0.24–0.54) 3.65 (2.99–4.30) 28.1 (26.3–29.8)
Negative predictive value 99.6 (99.4–99.7) 96.4 (95.7–97.0) 71.9 (70.2–73.7)
365 days
No. of events 54 134 753
Absolute risk 0.61 (0.45–0.78) 4.25 (3.55–4.96) 29.2 (27.4–31.0)
Negative predictive value 99.4 (99.2–99.5) 95.7 (95.0–96.5) 70.8 (69.0–72.6)
Death
30 days
No. of events 2 13 66
Absolute risk 0.023 (0.001–0.054) 0.41 (0.19–0.64) 2.56 (1.95–3.17)
Negative predictive value 100.0 (99.9–100.0) 99.6 (99.4–99.8) 97.4 (96.8–98.1)
180 days
No. of events 15 66 216
Absolute risk 0.17 (0.083–0.25) 2.09 (1.59–2.59) 8.38 (7.31–9.44)
Negative predictive value 99.8 (99.7–99.9) 97.9 (97.4–98.4) 91.6 (90.6–92.7)
365 days
No. of events 38 108 342
Absolute risk 0.43 (0.29–0.56) 3.43 (2.79–4.06) 13.3 (12.0–14.6)
Negative predictive value 99.6 (99.4–99.7) 96.6 (95.9–97.2) 86.7 (85.4–88.0)
*According to the ﬁrst high-sensitivity cardiac troponin T level, in 14,612y patients who sought medical attention for chest pain at Karolinska
University Hospital from December 2010 to December 2012. yTwenty-four patients with a ﬁrst high-sensitivity cardiac troponin T level of <5 ng/l
were excluded because they had electrocardiographic changes suggestive of myocardial infarction at the time of presentation to the emergency
department. Absolute risks and negative predictive values are given as percentage (95% conﬁdence interval).
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2573had at least 1 hs-cTnT level measured. Laboratory results
showed that 61% of these patients had a ﬁrst hs-cTnT level
of <5 ng/l, 21% had a ﬁrst hs-cTnT level of 5 to 14 ng/l,
and 18% had a ﬁrst hs-cTnT level of >14 ng/l (Table 1).
Patients with a ﬁrst hs-cTnT level of <5 ng/l were younger;
were less likely to have chronic kidney disease, chronic
cardiovascular disease, or diabetes mellitus; and were less
likely to be taking medications for secondary prevention
of cardiovascular disease (Table 1). With increasing levels of
hs-cTnT, patients were older, more often men, and had
more comorbidities.
Admissions, second high-sensitivity cardiac troponin T
levels, and discharge diagnoses. A total of 5,418 (37%)
patients were admitted to the hospital, of whom 35% had a
ﬁrst hs-cTnT level of <5 ng/l (Table 2, Fig. 1). The hospital
stay rate was 21% in patients with a ﬁrst hs-cTnT level
of <5 ng/l, 44% in patients with a ﬁrst hs-cTnT level of 5
to 14 ng/l, and 82% in patients with a ﬁrst hs-cTnT level of
>14 ng/l (Table 2). Among patients with a ﬁrst hs-cTnT
level of <5 ng/l, 1,704 (89%) had a second hs-cTnT level
measured, which was <5 ng/l in 1,362 (90%) patients, 5 to
14 ng/l in 111 (7.3%) patients, and >14 ng/l in 44 (3.0%)patients. Patients with a ﬁrst hs-cTnT level of <5 ng/l
and no MI within 30 days were admitted to the hospital
for a total of 3,262 days, with a mean duration of hospital stay
of 1.5  3.0 days; 1,482 (77%) of these patients were dis-
charged on the same or next day. Themost common discharge
diagnoses in patients with a ﬁrst hs-cTnT level of <5 ng/l
were nonspeciﬁc chest pain (50%), atrial ﬁbrillation or
supraventricular tachycardia (5.6%), and angina (5.1%)
(Table 3). A diagnosis of MI was unusual (2.0%) in patients
with a ﬁrst hs-cTnT level of <5 ng/l, but was more common
with higher hs-cTnT levels (26%) in patients with a ﬁrst
hs-cTnT level of >14 ng/l (Table 3). Among patients with a
ﬁrst hs-cTnT level of <5 ng/l, the time spent in the ED was
similar for those who were discharged compared with those
who were admitted to the hospital (208 101 min vs. 203
111 min). Time in the ED in relation to level of troponin and
ﬁnal diagnosis of MI is described in Online Table 1.
Myocardial infarction and death. A total of 746 (14%)
patients were discharged from the index hospital stay with a
diagnosis of MI. Forty-four patients with a ﬁrst hs-cTnT
level of <5 ng/l were diagnosed with MI within 30 days.
No patient was diagnosed with type 2 MI in the group with
Table 3
The 12 Most Common Discharge Diagnoses for Patients Admitted to Hospital,
According to the First High-Sensitivity Cardiac Troponin T Level
High-Sensitivity Cardiac Troponin T Level (ng/l)
<5
(n ¼ 1,917)
5–14
(n ¼ 1,397)
>14
(n ¼ 2,104)
Chest pain, % 50.0 Chest pain 34.0 MI 26.0
A-ﬁb/SVT, % 5.6 Angina 8.1 Chest pain 13.0
Angina, % 5.1 A-ﬁb/SVT 7.5 Heart failure 8.7
Abdominal pain, % 2.8 MI 3.0 A-ﬁb/SVT 7.2
Myalgia, % 2.4 Unstable angina 3.2 Angina 4.2
MI, % 2.0 Heart failure 3.1 Pneumonia 4.1
Pneumonia, % 1.8 Pneumonia 2.3 Unstable angina 2.4
Syncope, % 1.8 Syncope 1.9 Myocarditis 1.6
Hypertension, % 1.6 Myalgia 1.7 PE 1.2
Unstable angina, % 1.5 Hypertension 1.4 Syncope 1.2
PE, % 1.3 PE 1.3 Aortic stenosis 1.1
Palpitations, % 1.0 Dyspnea 1.2 Hypertension 0.9
Values are %. Chest pain was deﬁned as International Classiﬁcation of Diseases, 10th Revision codes R07.4, R07.3, Z03.4, or Z03.5; atrial ﬁbrillation
(A-ﬁb) as I48.9; supraventricular tachycardia (SVT) as I47.1; myalgia as M79.1; syncope as R55.9; hypertension as I10.9; unstable angina as I20.0;
pulmonary embolism (PE) as I26.9; palpitations as R00.2; pneumonia as J18.9; abdominal pain as R10.4, K29.7, or K85.9; dyspnea as R06.0; aortic
stenosis as I35.0; myocarditis as I40.9; and myocardial infarction (MI) as I21.4, I21.9, or I21.1.
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2574undetectable troponin levels. Two of these patients had a
periprocedural MI, and 3 did not meet the current criteria
for MI (2).
These 5 patients were excluded from further analysis.
Twenty-four of the remaining patients had signiﬁcant
ECG changes, of whom 15 (62%) were diagnosed withFigure 2 Patients With Undetectable High-Sensitivity Cardiac Tropon
All 39 patients with an initial high-sensitivity cardiac troponin T (hs-cTnT) <5 ng/l and an
infarction (MI) within 30 days of follow-up. LAD ¼ left anterior descending artery; LCX ¼ le
artery; STEMI ¼ ST-segment elevation myocardial infarction; NSTEMI, non–ST-segment eST-segment elevation myocardial infarction (STEMI) and 9
(38%) who were diagnosed with non–ST-segment elevation
myocardial infarction (NSTEMI) (Fig. 2). No patient had a
left bundle branch block on the ECG.
In 15 of the remaining 39 patients, there were no sig-
niﬁcant changes on the ﬁrst ECG performed in the EDin T and Myocardial Infarction Within 30 Days
electrocardiogram (ECG) without ST-segment elevation or depression, but myocardial
ft circumﬂex artery; PCI ¼ percutaneous coronary intervention; RCA ¼ right coronary
levation myocardial infarction; other abbreviations as in Figure 1.
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2575(Table 4, Fig. 2). These patients were older, more often men
(73%), and had previous cardiovascular disease (20%) more
frequently than patients with hs-cTnT <5 ng/l and no MI.
In addition, they were often active smokers (40%). The ﬁrst
hs-cTnT level was measured within 2 h of the onset of
symptoms in 11 (73%) patients, and >3 h after the onset of
symptoms in 2 (13%) patients. One patient was discharged
directly from the ED and was readmitted with a diagnosis of
STEMI after 18 days. In 2 patients, a second ECG within
1 h of the ﬁrst ECG showed ST elevation, and in another
patient, the ED physician judged the ECG to be consistent
with a diagnosis of STEMI. These 4 patients underwent
primary PCI. In the 11 patients who did not undergo im-
mediate cardiac catheterization, the maximum hs-cTnT level
ranged from 18 to 157 ng/l. In 5 (45%) of these 11 patients,
the maximum hs-cTnT level was <30 ng/l (Table 4).
A ﬁrst hs-cTnT level of <5 ng/l in combination with no
signs of ischemia on the ECG had a negative predictive value
for MI of 99.8% (95% CI: 99.7 to 99.9) and an absolute risk
for MI of 0.17% (95% CI: 0.09 to 0.27) (Table 2). MI
occurred in 39 patients with a ﬁrst hs-cTnT level of <5 ng/l
at 30 to 365 days after discharge from the ED, which is an
incidence of 7.36 (95% CI: 5.55 to 9.58) per 1,000 person-
years. In patients with a ﬁrst hs-cTnT level of 5 to 14 ng/l,
the absolute risk of MI within 30 days was 3.1%, and the
negative predictive value forMI within 30 days was 96.9%. In
patients with a ﬁrst hs-cTnT level of >14 ng/l, the absolute
risk of MI within 30 days was 26.2%, and the negative pre-
dictive value for MI within 30 days was 73.8% (Table 2).
In patients with a ﬁrst hs-cTnT level of <5 ng/l and no
signs of ischemia on the ECG, the negative predictive value
for death within 30 days was 100% (95% CI: 99.9 to 100.0)
(Table 2), and there were 38 deaths during the 365 days
after discharge from the ED. The underlying cause of death
was cardiovascular disease in 2 (5%) patients, cancer in 32
(84%) patients, and another cause in 4 (11%) patients.
Among patients with a ﬁrst hs-cTnT level of <5 ng/l,
there was no signiﬁcant difference in the risk of death within
365 days between those who were discharged directly from
the ED and those who were admitted to the hospital after
adjustment for age, sex, diabetes mellitus, previous MI, and
eGFR (hazard ratio: 0.73; 95% CI: 0.48 to 1.12).
Discussion
In a large cohort of 14,636 consecutive patients who sought
medical attention for chest pain in the ED, we found that a
ﬁrst hs-cTnT level of <5 ng/l combined with no signs of
ischemia on the ECG had a 99.8% negative predictive value
for MI and a 100% negative predictive value for death within
30 days.
Cardiac troponins have been used as a cornerstone of
diagnosis of MI, together with clinical assessment and ECG
ﬁndings, for more than 15 years (15). However, a limitation
of former generations of troponin assays have been that they
required at least 6 h from the onset of symptoms before theywould be detectable (14). Repeated testing was often
required, leading to unnecessary hospital stays for investi-
gation of chest pain. Recently, high-sensitivity cardiac tro-
ponins have been introduced into clinical practice (10,16).
They increase diagnostic accuracy by identifying a larger
proportion of patients with MI at the time of presentation to
the ED. Because elevation of high-sensitivity cardiac
troponin levels are detectable at a much earlier stage than
earlier generations of troponin assays (10,14,16), they have
been suggested to have the potential to rule out MI at an
earlier stage (5–8,10,11,16).
Two recent studies investigated the negative predictive
value of an initial undetectable hs-cTnT for MI (5,11). In
both of these studies, patients were recruited prospectively at
the discretion of the ED physician, serial hs-cTnT levels
were measured, and only patients admitted to the hospital
were included. In another study, a second troponin mea-
surement was taken 1 h after the ﬁrst, and was used to rule
out patients with MI (8). In all 3 studies, the negative
predictive value for MI was almost 100% if hs-cTnT was
undetectable. In contrast to these 3 studies, the present study
included all patients who presented to the ED with a main
complaint of chest pain, and used the ﬁrst hs-cTnT level
and ECG ﬁndings to rule out MI, without assessment of the
pretest probability of MI and without serial measurements of
hs-cTnT levels. This simple strategy conﬁrmed the ﬁndings
of the 2 previous studiesdthat an undetectable ﬁrst hs-
cTnT level rules out MI with almost 100% accuracy.
Chest pain was the second most common reason for
presentation to the ED during the study period, and 61% of
patients with a main complaint of chest pain had a ﬁrst hs-
cTnT level of <5 ng/l. Hospital stay occurred in 21% of
these patients, accounting for one-third of all patients
admitted to the hospital because of chest pain. This indicates
that 594 patients with a ﬁrst hs-cTnT level of <5 ng/l would
have to be admitted to detect 1 additional MI. More than
two-thirds of the patients with a ﬁrst hs-cTnT level
of <5 ng/l who were admitted to the hospital were dis-
charged on the same day or the next day, and 50% had a
discharge diagnosis of nonspeciﬁc chest pain. Although
some of these patients may have had other conditions
requiring hospital stay such as heart failure, atrial ﬁbrilla-
tion, or pulmonary embolism, we believe that hospital stay
could have been avoided in the majority of these patients,
resulting in an annual decrease of 600 to 700 admissions to
our hospital, which corresponds to a 20 to 25% reduced
admission rate of patients with chest pain. Considering that
an estimated 15 to 20 million patients seek medical attention
at an ED for chest pain every year in Europe and the United
States, the potential savings for healthcare providers are
enormous (1–3).
Only 15 of all patients who presented to our ED during
the study were diagnosed with MI despite having an un-
detectable ﬁrst hs-cTnT level combined with no signs of
ischemia on the initial ECG. The ﬁrst hs-cTnT level was
measured <2 h after the onset of symptoms in 11 of these
Table 4
Details of 15 Patients With Chest Pain and a First High-Sensitivity Cardiac Troponin T Level of <5 ng/l Combined
With No Signs of Ischemia on an Electrocardiogram, Who Had a Final Diagnosis of Myocardial Infarction
Sex Age, yrs Previous Medical History Current Medical History
Time from Onset
of Symptoms to
1st, 2nd and 3rd
hs-cTnT Level
ECG Assessment by
the ED Physician Clinical Course
Male 48 This patient had COPD,
never smoked, and
had
a BMI of 31 kg/m2.
Sudden onset of chest pain
and tachycardia in the
morning.
<1 h: <5 ng/l
6–7 h: 33 ng/l
12–13 h: 23 ng/l
SR, 108 beats/min,
no signs of ischemia.
Coronary angiography was
performed on day 3, and
a stent was placed in the
LAD. The ﬁnal diagnosis
was NSTEMI.
Female 52 This patient had
hypertension, was an
ex-smoker, and had a
BMI of 22 kg/m2.
Sudden onset of chest
discomfort in the
morning.
2–3 h: <5 ng/l
8–9 h: 18 ng/l
14–15 h: 9 ng/l
SR, 97 beats/min,
nonspeciﬁc ST-segment
changes in leads V4–V6.
Coronary angiography on
day 4 was normal. The
ﬁnal diagnosis was
NSTEMI.
Male 39 This patient had
hypertension, was an
ex-smoker, and had a
BMI of 28 kg/m2.
Sudden onset of chest
pain and nausea during
physical activity.
1–2 h: <5 ng/l
7–8 h: 1,930 ng/l
SR, 55 beats/min,
ST-segment elevation
in leads II and aVF.
Primary PCI was
performed, and a stent
was placed in the RCA.
The ﬁnal diagnosis was
STEMI.
Male 64 This patient was a
previously healthy
smoker and had a
BMI of 28 kg/m2.
Sudden left-sided stabbing
sensation in the chest.
<1 h: <5 ng/l SR, 85 beats/min,
no signs of ischemia.
This patient was
discharged from the ED,
but returned after
18 days with STEMI,
which was treated with
primary PCI with
stenting of the LAD.
Male 57 This patient had a
previous
CABG, never smoked,
and had a BMI of
25 kg/m2.
Sudden onset of chest
pain and nausea in
the morning.
1–2 h: <5 ng/l
7–8 h: 0.16 ng/l*
13–14 h: 0.34 ng/l*
SR, 63 beats/min,
Q-wave in lead III.
Coronary angiography was
performed on day 3, and
a stent was placed in the
RCA. The ﬁnal diagnosis
was NSTEMI.
Male 59 This patient had
hypertension, was
a current smoker,
and had a BMI
of 27 kg/m2.
Sudden onset of chest
pain during the night.
1–2 h: <5 ng/l
7–8 h: 81 ng/l
13–14 h: 149 ng/l
SR, ST-segment
depression
in leads I and aVL.
Coronary angiography was
performed on day 3, and
a stent was placed in the
RCA. The ﬁnal diagnosis
was NSTEMI.
Male 62 This patient was a
nonsmoker and had
a BMI of 28 kg/m2.
Sudden onset of recurrent
chest pain.
1–2 h: <5 ng/l
7–8 h: 21 ng/l
13–14 h: 21 ng/l
SR, 107 beats/min,
no signs of ischemia.
Coronary angiography was
performed on day 2, and
a stent was placed in the
LAD. The ﬁnal diagnosis
was NSTEMI.
Female 72 This patient was a
current
smoker and had a BMI
of 22 kg/m2.
Sudden onset of left-sided
chest pain in the
morning.
<1 h: <5 ng/l
6–7 h: 4,560 ng/l
SR, 45 beats/min,
no signs of ischemia.
A second ECG performed
1 h after the ﬁrst ECG
showed ST-segment
elevation in the inferior
leads. Primary PCI was
performed, and a stent
was placed in the LCX.
The ﬁnal diagnosis was
STEMI.
Male 68 This patient had
hypertension, was a
nonsmoker, and had
a BMI of 31 kg/m2.
Sudden onset of chest
pain, diaphoresis,
nausea, and dyspnea.
2–3 h: <5 ng/l
8–9 h: 18 ng/l
14–15 h: 15 ng/l
SR, 110 beats/min,
no signs of ischemia.
Coronary angiography was
performed on day 4, and
was normal. The ﬁnal
diagnosis was NSTEMI.
Male 64 This patient was a
current
smoker and had a BMI
of 31 kg/m2.
Sudden onset of chest pain
and diaphoresis at noon.
1–2 h: <5 ng/l
7–8 h: 158 ng/l
13–14 h: 888 ng/l
SR, 60 beats/min,
T-wave inversion
in leads V1 and V2.
A second ECG performed
30 min after the ﬁrst
ECG showed ST-segment
elevation in the inferior
leads. Primary PCI was
performed, and a stent
was placed in the RCA.
The ﬁnal diagnosis was
STEMI.
Continued on the next page
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Table 4 Continued
Sex Age, yrs Previous Medical History Current Medical History
Time from Onset
of Symptoms to
1st, 2nd and 3rd
hs-cTnT Level
ECG Assessment by
the ED Physician Clinical Course
Male 56 This patient was a
current
smoker and had a BMI
of 20 kg/m2.
Sudden onset of chest pain
during physical activity.
1–2 h: <5 ng/l
7–8 h: 29 ng/l
13–14 h: 56 ng/l
SR, no signs of
ischemia.
Coronary angiography was
performed on day 5, and
was normal. The ﬁnal
diagnosis was NSTEMI.
Female 68 This patient had 3
previous
MIs and a previous
CABG,
was an active smoker,
and had a BMI of
17 kg/m2.
Sudden onset of left-sided
chest pain during
physical activity.
>3 h: <5 ng/l
>9 h: 40 ng/l
SR, 60 beats/min,
no signs of ischemia.
Coronary angiography was
performed on day 2 and
showed no signiﬁcant
stenosis. The ﬁnal
diagnosis was NSTEMI.
Female 56 This patient was an
active
smoker and had a BMI
of 27 kg/m2.
Sudden onset of chest pain
during the night.
<1 h: <5 ng/l
6–7 h: 19 ng/l
SR, 76 beats/min,
no signs of ischemia.
ECG later on the day of
admission showed
ST-segment elevation.
Coronary angiography
showed no signiﬁcant
stenosis. The ﬁnal
diagnosis was STEMI.
Male 54 This patient had
hypertension,
was an ex-smoker,
and had a BMI of
26 kg/m2.
Sudden onset of chest pain
in the morning.
1–2 h: <5 ng/l
7–8 h: 157 ng/l
13–14 h: 92 ng/l
SR, nonsigniﬁcant
ST-segment elevation
in leads V3–V6.
Coronary angiography was
performed on day 3 and
showed no signiﬁcant
stenosis. The ﬁnal
diagnosis was NSTEMI.
Male 72 This patient had a
previous
stroke, was a
nonsmoker,
and had a BMI of
24 kg/m2.
Sudden onset of chest pain
during the night.
>3 h: <5 ng/l
>9 h: 12 ng/l
> 15 h: 29 ng/l
SR, no signs of ischemia. Coronary angiography was
performed on day 3 and
showed no signiﬁcant
stenosis. The ﬁnal
diagnosis was NSTEMI.
*This patient had cardiac troponin I analyzed after he was admitted to the cardiac care unit.
BMI ¼ body mass index; BP ¼ blood pressure; ECG ¼ electrocardiogram; hs-cTnT ¼ high-sensitivity cardiac troponin T; LAD ¼ left anterior descending artery; LCX ¼ left circumﬂex artery; MI ¼ myocardial
infarction; PCI ¼ percutaneous coronary intervention; RR ¼ respiratory rate; SR ¼ sinus rhythm; STEMI ¼ ST-segment elevation myocardial infarction.
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tained 3 to 4 h after onset of symptoms, most likely it would
have been signiﬁcantly elevated in most of these patients.
Because chest pain is 1 of the most common symptoms in
patients seeking medical attention in the ED, our strategy
may help to reduce overcrowding of the ED. However, our
results did not show that low-risk patients who are admitted
to the hospital spend more time in the ED than those who
are discharged directly from the ED.
There were only 2 cardiovascular deaths in patients
with undetectable hs-cTnT levels during the year that
followed the visit to the ED. This indicates that hs-cTnT
may not only be a predictor of early, but also long-term,
prognosis (17).
There may have been several patients among those with
undetectable levels of hs-cTnT who were discharged from
the ED, who, if they were admitted to the hospital, would
have had elevated hs-cTnT levels subsequently. We calcu-
lated the risk of death within the year after the visit to the
ED for patients who were admitted compared with patients
who were discharged directly from the ED and found no
difference.
It is very important to determine whether patients with a
very small elevation of the ﬁrst hs-cTnT level beneﬁt frombeing diagnosed with MI. There were two procedure-related
MIs in patients with undetectable hs-cTnT levels. Because
MI after PCI has a worse prognosis than PCI without MI
(18), a diagnosis of MI based on a very small elevation of
the hs-cTnT level may increase the risk to the patient. In
almost half of the patients diagnosed with MI who had a
ﬁrst hs-cTnT level of <5 ng/l combined with no signs
of ischemia on the ECG, the maximum hs-cTnT level
was <30 ng/l. With earlier generations of troponin assays,
these patients would probably not have been diagnosed with
MI (14).
To the best of our knowledge, this is the ﬁrst study of
such a large cohort of consecutive patients (n ¼ 14,636) who
sought medical attention for chest pain, and had information
on hs-cTnT levels at an ED over a 2-year period. Patient
follow-up was complete because follow-up data were ob-
tained from national registers.
Conclusions
We found that a ﬁrst hs-cTnT level of <5 ng/l combined
with no signs of ischemia on ECG ruled out MI with nearly
100% accuracy, regardless of previous disease, timing of
measurement of the hs-cTnT level, age, sex, or other risk
factors for MI.
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